ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 104 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2019. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $18,081 | -68.3% | 31,200 | -48.0% | 0.00% | – |
| Q3 2022 | $57,000 | -20.8% | 60,000 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $72,000 | -8.9% | 60,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $79,000 | -94.6% | 60,000 | -57.8% | 0.00% | -96.4% |
| Q3 2020 | $1,465,000 | -37.3% | 142,295 | +27.1% | 0.03% | -9.7% |
| Q2 2020 | $2,338,000 | +1898.3% | 111,994 | +838.1% | 0.03% | +342.9% |
| Q1 2020 | $117,000 | -89.7% | 11,938 | -88.0% | 0.01% | -75.0% |
| Q4 2019 | $1,141,000 | -69.5% | 99,091 | -85.6% | 0.03% | -74.5% |
| Q3 2019 | $3,742,000 | – | 686,700 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 5,068,233 | $17,739,000 | 5.88% |
| Sonic Fund II, L.P. | 6,552,068 | $22,932,000 | 1.69% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $1,680,000 | 0.88% |
| Avoro Capital Advisors LLC | 6,950,000 | $24,325,000 | 0.42% |
| RTW INVESTMENTS, LP | 7,357,917 | $25,753,000 | 0.39% |
| K2 PRINCIPAL FUND, L.P. | 898,307 | $3,144,000 | 0.26% |
| Artal Group S.A. | 3,000,000 | $10,500,000 | 0.21% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,827,000 | $9,895,000 | 0.18% |
| WS MANAGEMENT LLLP | 307,442 | $1,076,000 | 0.11% |
| ALGERT GLOBAL LLC | 82,145 | $288,000 | 0.10% |